|4Feb 5, 5:30 PM ET

Zojwalla Naseem 4

4 · Olema Pharmaceuticals, Inc. · Filed Feb 5, 2024

Insider Transaction Report

Form 4
Period: 2024-02-01
Zojwalla Naseem
CHIEF MEDICAL OFFICER
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-02-01+195,000195,000 total
    Exercise: $15.25Exp: 2034-01-31Common Stock (195,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option vest on February 1, 2025 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Documents

1 file
  • 4
    form4-02052024_050213.xmlPrimary